Sulforaphane bioavailability and chemopreventive activity in women scheduled for breast biopsy

Cancer Prevention Research

Volumn 8, Issue 12, 2015, Pages 1184-1191

  Atwell, Lauren L ^a,b   Zhang, Zhenzhen ^c   Mori, Motomi ^c   Farris, Paige E ^c   Vetto, John T ^c   Naik, Arpana M ^c   Oh, Karen Y ^d   Thuillier, Philippe ^c,d   Ho, Emily ^a,e   Shannon, Jackilen ^c  

^a OREGON STATE UNIVERSITY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCORAPHANIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 6; KI 67 ANTIGEN; PLACEBO; PROTEIN P21; SULFORAPHANE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; SULFORAFAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SCREENING; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; BIOAVAILABILITY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIETARY SUPPLEMENT; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; PROCEDURES;

ANTICARCINOGENIC AGENTS; BIOLOGICAL AVAILABILITY; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOPREVENTION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOTHIOCYANATES; MASS SPECTROMETRY;

EID: 84951933721     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0119     Document Type: Article

References (49)

1. Tortorella SM, Royce SG, Licciardi PV, Karagiannis TC. Dietary sulforaphane in cancer chemoprevention: The role of epigenetic regulation and HDAC inhibition. Antiox Redox Signal 2015;22:1382-424.
2. Ambrosone CB, McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 2004;134:1134-8.
3. Liu X, Kezhen L. Cruciferous vegetables intake is inversely associated with risk of breast cancer: A meta-analysis. Breast 2013;22:309-13.
4. Fuentes F, Paredes-Gonzalez X, Kong AT. Dietary glucosinolates sulforaphane, phenethyl isothiocyanate, indole-3-carbinol/3, 30-diindolylmethane: Antioxidative stress/inflammation, Nrf2, epigenetics/epigenomics and in vivo cancer chemopreventive efficacy. Curr Pharmacol Rep 2015;1:179-96.
5. Vatovec C, Erten MZ, Kolodinsky J, Brown P, Wood M, James T, et al. Ductal carcinoma in situ: A brief review of treatment variation and impacts on patients and society. Crit Rev Euk Gene Expr 2014;24:281-6.
6. Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 2010;102:170-8.
7. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, et al. National institutes of health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 2010;102:161-9.
8. Sprague BL, Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Change in lifestyle behaviors andmedication use after a diagnosis of ductal carcinoma in situ. Breast Cancer Res Treat 2010;124:487-95.
9. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci 1997;94:10367-72.
10. Li F, HullarMA, Beresford SA, Lampe JW. Variation of glucoraphanin metabolism in vivo and ex vivo by human gut bacteria. Br J Nutr 2011;106:408-16.
11. Brandi G, Schiavano GF, Zaffaroni N, De Marco C, Paiardini M, Cervasi B, et al. Mechanisms of action and antiproliferative properties of Brassica oleracea juice in human breast cancer cell lines. J Nutr 2005;135:1503-9.
12. Gill CI, Haldar S, Porter S, Matthews S, Sullivan S, Coulter J, et al. The effect of cruciferous and leguminous sprouts on genotoxicity, in vitro and in vivo. Cancer Epidemiol Biomarkers Prev 2004;13:1199-205.
13. Jackson SJ, Singletary KW. Sulforaphane: A naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis. 2004;25:219-27.
14. Johnston N. Sulforaphane halts breast cancer cell growth. Drug Discov Today 2004;9:908.
15. Kanematsu S, Yoshizawa K, Uehara N, Miki H, Sasaki T, Kuro M, et al. Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol Rep 2011;26:603-8.
16. Shankar S, Ganapathy S, Srivastava RK. Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin Cancer Res 2008;14:6855-66.
17. Inwald EC, Klinkhammer-Schalke M, Hofstadter F, Zeman F, Koller M, Gerstenhauer M, et al. Ki-67 is a prognostic parameter in breast cancer patients: Results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 2013;139:539-52.
18. Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice. FASEB J 2006;20:506-8.
19. Myzak MC, Karplus PA, Chung FL, Dashwood RH. A novel mechanism of chemoprotection by sulforaphane. Cancer Res 2004;64:5767-74.
20. Glaser KB, Staver MJ, Waring JF, Stender J, Ulrich RG, Davidsen SK. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther 2003;2:151-63.
21. Yang X, Ferguson AT, Nass SJ, Phillips DL, Butash KA, Wang SM, et al. Transcriptional activation of estrogen receptor a in human breast cancer cells by histone deacetylase inhibition. Cancer Res 2000;60:6890-4.
22. Alao JP, Lam EW, Ali S, Buluwela L, Bordogna W, Lockey P, et al. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alphadependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. Clin Cancer Res 2004;10: 8094-104.
23. Bali P, Pranpat M, Swaby R, Fiskus W, Yamaguchi H, Balasis M, et al. Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2. Clin Cancer Res 2005;11:6382-9.
24. Lakshmaiah K, Jacob L, Aparna S, Lokanatha D, Saldanha S. Epigenetic therapy of cancer with histone deacetylase inhibitors. J Cancer Res Ther 2014;10:469-78.
25. Shapiro TA, Fahey JW, Dinkova-Kostova AT, Holtzclaw WD, Stephenson KK, Wade KL, et al. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: A clinical phase I study. Nutr Cancer 2006;55:53-62.
26. Bolignano D, Mattace-Raso F, Torino C, D'Arrigo G, ElHafeez SA, Provenzano F, et al. The quality of reporting in clinical research: The CONSORT and STROBE initiatives. Aging Clin Exp Res 2013;25:9-15.
27. Kensler TW, Chen J, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin- DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev 2005;14:2605-13.
28. Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibitsHDACactivity in human subjects. Exp Biol Med 2007;232:227-34.
29. Thomson CA, Newton TR, Graver EJ, Jackson KA, Reid PM, Hartz VL, et al. Cruciferous vegetable intake questionnaire improves cruciferous vegetable intake estimates. J Am Diet Assoc 2007;107:631-43.
30. Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, Stevens JF, et al. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res 2011;64:456-63.
31. Tian Q, Rosselot RA, Schwartz SJ. Quantitative determination of intact glucosinolates in broccoli, broccoli sprouts, Brussels sprouts, and cauliflower by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Analyt Biochem 2005;343: 93-9.
32. Clarke JD, Hsu A, Williams DE, Dashwood RH, Stevens JF, Yamamoto M, et al. Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res 2011;28:3171-9.
33. Atwell LL, Hsu A, Wong CP, Stevens JF, Bella D, Yu T-W, et al. Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. Mol Nutr Food Res 2015;59:424-33.
34. Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM, et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 2009;69: 3802-9.
35. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 1995;57: 289-300.
36. Stearns V, Jacobs LK, Fackler MJ, Tsangaris TN, Rudek MA, Higgins M, et al. Biomarker modulation following short-term Vorinostat in women with newly diagnosed primary breast cancer. Clin Cancer Res 2013;19: 4008-16.
37. Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006;27:9.
38. Pledgie-Tracy A, Sobolewski MD, Davidson NE. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 2007;6:1013-21.
39. Clarke JD, Riedl K, Bella D, Schwartz SJ, Stevens JF, Ho E. Comparison of isothiocyanatemetabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement. J Agric Food Chem 2011;59:10955-63.
40. Liu Q, Merkler KA, Zhang X, McLean MP. Prostaglandin F2a suppresses rat steroidogenic acute regulatory protein expression via induction of yin yang 1 protein and recruitment of histone deacetylase 1 protein. Endocrinology 2007;148:5209-19.
41. Rajendran P, Delage B, Dashwood MW, Yu T-W, Wuth B, Williams DE, et al. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol Cancer 2011;10:68.
42. Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res 2011;55:999-1009.
43. Suzuki J, Chen Y-Y, Scott GK, DeVries S, Chin K, Benz CC, et al. Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression. Clin Cancer Res 2009;15:3163-71.
44. Gibbs A. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Proc Natl Acad Sci U S A 2009;106:16663-8.
45. Vigushin DM, Simak A, Pace PE, Mirsaidi N, Ito K, Adcock I, et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res 2001;7:971-6.
46. Sambuccetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, et al. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 1999;274: 34940-7.
47. Gui C. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci 2004;101:1241-6.
48. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008;40:897-903.
49. Jung Y-S. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010;22:1003-12.